Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Accounts Payables (2016 - 2025)

SRx Health Solutions' Accounts Payables history spans 15 years, with the latest figure at $2.1 million for Q3 2025.

  • For Q3 2025, Accounts Payables fell 94.61% year-over-year to $2.1 million; the TTM value through Sep 2025 reached $2.1 million, down 94.61%, while the annual FY2025 figure was $2.1 million, N/A changed from the prior year.
  • Accounts Payables reached $2.1 million in Q3 2025 per SRXH's latest filing, down from $38.4 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $39.8 million in Q3 2024 to a low of $100000.0 in Q3 2023.
  • Average Accounts Payables over 5 years is $7.7 million, with a median of $4.4 million recorded in 2025.
  • Peak YoY movement for Accounts Payables: tumbled 97.4% in 2023, then surged 39742.0% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $4.6 million in 2021, then crashed by 35.6% to $2.9 million in 2022, then soared by 136.29% to $6.9 million in 2023, then crashed by 54.72% to $3.1 million in 2024, then tumbled by 31.56% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Accounts Payables are $2.1 million (Q3 2025), $38.4 million (Q2 2025), and $4.4 million (Q1 2025).